Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2020

Aug 14, 2020

SELL
$10.21 - $14.9 $15.3 Million - $22.3 Million
-1,499,970 Closed
0 $0
Q1 2020

May 15, 2020

BUY
$8.08 - $17.57 $2.69 Million - $5.85 Million
333,234 Added 28.56%
1,499,970 $17 Million
Q4 2019

Feb 14, 2020

BUY
$8.11 - $14.65 $1.75 Million - $3.15 Million
215,209 Added 22.62%
1,166,736 $15.3 Million
Q4 2018

Feb 14, 2019

BUY
$5.61 - $12.62 $2.01 Million - $4.53 Million
358,725 Added 60.51%
951,527 $6 Million
Q3 2018

Nov 14, 2018

BUY
$9.0 - $14.9 $5.34 Million - $8.83 Million
592,802 New
592,802 $7.83 Million

Others Institutions Holding XENE

About Xenon Pharmaceuticals Inc.


  • Ticker XENE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,263,500
  • Market Cap $2.39B
  • Description
  • Xenon Pharmaceuticals Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutics to treat patients with neurological disorders in Canada. Its clinical development pipeline includes XEN496, A Kv7 potassium channel opener that is Phase III clinical trials for the treatment of KCNQ2 developmental and epilepsy encephalopath...
More about XENE
Track This Portfolio

Track Aquilo Capital Management, LLC Portfolio

Follow Aquilo Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Aquilo Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aquilo Capital Management, LLC with notifications on news.